The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Henderson Michael Thomas since 2019.
This trader's CIK number is 1779990.
At the time of last reporting, Henderson Michael Thomas was the Chief Executive Officer of Apogee Therapeutics, Inc.. (stock ticker symbol APGE).
Also see all insider trading activities at Apogee Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | APGE | 0 | $0 | 40,000 | $1,647,450 | 8,500 | $194,310 |
| 2024 | APGE | 0 | $0 | 165,000 | $7,975,820 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | BBIO | 0 | $0 | 103,850 | $3,767,594 | 123,990 | $65,909 |
| 2019 | BBIO | 7,000 | $119,000 | 0 | $0 | 173,767 | $0 |
1. Apogee Therapeutics, Inc. (APGE)
2. Bridgebio Pharma, Inc. (BBIO)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-03-05 | APGE | Sale | 10,000 | 30.30 | 303,000 |
| 2025-02-05 | APGE | Sale | 15,000 | 40.58 | 608,700 |
| 2025-01-31 | APGE | Option Ex | 8,500 | 22.86 | 194,310 |
| 2025-01-08 | APGE | Sale | 15,000 | 49.05 | 735,750 |
| 2024-12-04 | APGE | Sale | 15,000 | 46.84 | 702,675 |
| 2024-11-06 | APGE | Sale | 15,000 | 59.55 | 893,325 |
| 2024-10-02 | APGE | Sale | 40,000 | 56.41 | 2,256,200 |
| 2024-09-04 | APGE | Sale | 40,000 | 47.76 | 1,910,200 |
| 2024-08-07 | APGE | Sale | 40,000 | 41.36 | 1,654,520 |
| 2024-07-05 | APGE | Sale | 15,000 | 37.26 | 558,900 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-06-03 | BBIO | Sale | 784 | 30.04 | 23,548 |
| 2020-12-01 | BBIO | Sale | 10,000 | 51.41 | 514,080 |
| 2020-12-01 | BBIO | Option Ex | 10,000 | 1.05 | 10,500 |
| 2020-11-16 | BBIO | Option Ex | 22,813 | .53 | 11,976 |
| 2020-11-16 | BBIO | Sale | 10,000 | 45.00 | 450,000 |
| 2020-11-02 | BBIO | Option Ex | 10,000 | 1.05 | 10,500 |
| 2020-11-02 | BBIO | Sale | 10,000 | 38.62 | 386,210 |
| 2020-10-01 | BBIO | Sale | 10,000 | 38.78 | 387,840 |
| 2020-10-01 | BBIO | Option Ex | 10,000 | .67 | 6,650 |
| 2020-09-18 | BBIO | Option Ex | 10,000 | .22 | 2,200 |
| 2020-09-18 | BBIO | Sale | 10,000 | 40.00 | 400,000 |
| 2020-09-01 | BBIO | Sale | 10,000 | 28.74 | 287,370 |
| 2020-09-01 | BBIO | Option Ex | 10,000 | .16 | 1,600 |
| 2020-08-16 | BBIO | Option Ex | 12,812 | .00 | 0 |
| 2020-08-03 | BBIO | Sale | 10,000 | 27.70 | 276,970 |
| 2020-08-03 | BBIO | Option Ex | 10,000 | .16 | 1,600 |
| 2020-07-01 | BBIO | Sale | 10,000 | 31.69 | 316,890 |
| 2020-07-01 | BBIO | Option Ex | 10,000 | .16 | 1,600 |
| 2020-06-08 | BBIO | Sale | 606 | 30.03 | 18,195 |
| 2020-06-01 | BBIO | Sale | 2,585 | 29.53 | 76,329 |
| 2020-05-26 | BBIO | Option Ex | 18,365 | 1.05 | 19,283 |
| 2020-05-05 | BBIO | Sale | 1,460 | 30.48 | 44,493 |
| 2020-05-01 | BBIO | Sale | 2,585 | 29.53 | 76,327 |
| 2020-05-04 | BBIO | Sale | 1,320 | 30.01 | 39,613 |
| 2020-04-01 | BBIO | Sale | 2,585 | 26.49 | 68,474 |
| 2020-03-02 | BBIO | Sale | 3,975 | 32.55 | 129,370 |
| 2020-02-03 | BBIO | Sale | 3,975 | 34.90 | 138,731 |
| 2020-01-02 | BBIO | Sale | 3,617 | 33.58 | 121,469 |
| 2020-01-03 | BBIO | Sale | 358 | 32.64 | 11,685 |
| 2019-07-01 | BBIO | Buy | 7,000 | 17.00 | 119,000 |
| 2019-07-01 | BBIO | Option Ex | 173,767 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Henderson Michael Thomas (Chief Executive Officer of Apogee Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.